Maria Edith Tiscareno, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 29 years
- Oakland College of Medicine and Surgery, 1997
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Tiscareno’s office at (408) 885-5000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A68064 · Current
Licensed to practise in California · since 1999 · expires 2028-08-31 · Medical College of Wisconsin.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$1,918
Medicare paid this office $1,918 for 60 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| X-ray of chest, 2 views | 16 | $311 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 17 | $96 | $5 |
Who their Medicare patients are
60 Original Medicare patients in 2024. Average age 71 · Women 67% · Also on Medicaid 68% · Health risk score 1.17. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 73% · Diabetes 40% · Cancer 23% · Depression 22% · Coronary heart disease 18%.
The office billed $41,392, Medicare allowed $3,014 and paid $1,918; for 88 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 60 | 88 | 71 | 1.17 | $41,392 | $1,918 |
| 2023 | 39 | 59 | 70 | 1.02 | $27,852 | $1,749 |
| 2016 | 82 | 90 | 73 | 1.06 | $7,664 | $2,516 |
| 2015 | 75 | 91 | 73 | 1.41 | $7,873 | $3,142 |
| 2014 | 90 | 181 | 68 | 1.31 | $42,207 | $7,289 |
| 2013 | 56 | 99 | 67 | 1.60 | $24,498 | $4,166 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 16 | $103 | $6 |
2016: 2 services
| Short return visit | 64 | $1,772 | $25 |
| New patient visit (15+ min) | 14 | $602 | $43 |
2015: 2 services
| Short return visit (20+ min) | 21 | $1,174 | $43 |
| Short return visit | 45 | $1,014 | $22 |
2014: 5 services
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 19 | $2,717 | $143 |
| Return visit (30+ min) | 16 | $727 | $45 |
| Short return visit (20+ min) | 20 | $595 | $27 |
| X-ray of chest, 2 views, front and side | 11 | $229 | $19 |
| Computer analysis of screening mammogram to assist detection of cancer | 19 | $173 | $9 |
2013: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 11 | $94 | $9 |
Medicaid work
$450,870 in 2024
Medicaid paid $450,870 for 10,202 billed services this clinician did in 2024, up to 125 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 770 | $395,515 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 122 | $53,766 |
| Return visit (30+ min) | 852 | $472 |
| Short return visit (20+ min) | 883 | $351 |
| Thyroid stimulating hormone (TSH) | 246 | $216 |
| Hemoglobin A1C level | 293 | $128 |
| Blood test, lipids (cholesterol and triglycerides) | 176 | $104 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 193 | $85 |
| Short return visit | 170 | $69 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 317 | $62 |
| COMPREHENSIVE METABOLIC PANEL | 71 | $54 |
| Blood, occult, by fecal hemoglobin determination by immunoassay, qualitative, feces, 1-3 simultaneous determinations | 12 | $14 |
| 2024 | 10,202 | 32 | 125 | $450,870 |
| 2023 | 4,464 | 23 | 94 | $469,053 |
| 2022 | 1,031 | 8 | 45 | $102,782 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 922 | $458,236 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 23 | $10,170 |
| Short return visit (20+ min) | 1,164 | $299 |
| Return visit (30+ min) | 442 | $69 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 250 | $62 |
| Hemoglobin A1C level | 140 | $60 |
| Thyroid stimulating hormone (TSH) | 26 | $47 |
| Short return visit | 150 | $33 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 100 | $27 |
| Blood test, lipids (cholesterol and triglycerides) | 52 | $18 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 31 | $16 |
| COMPREHENSIVE METABOLIC PANEL | 13 | $15 |
2022
| Clinic visit/encounter, all-inclusive | 270 | $101,431 |
| Short return visit (20+ min) | 205 | $360 |
| Short return visit | 161 | $356 |
| Screening for depression is documented as negative, a follow-up plan is not required | 105 | $337 |
| Alcohol and/or drug screening | 73 | $299 |
| BODY MASS INDEX DOCD | 84 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 75 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 58 | $0 |
Drugs they prescribed that Part D paid
$287,136
Pharmacies billed $287,136 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (56 of 2,595) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%. Long-acting opioids: 23% of their opioid prescriptions.
2,183 generic and 387 brand-name prescriptions · $287,136 in drug cost · 44 antibiotic prescriptions to 34 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 50 | $48,457 | $969 |
| Jardiance | 33 | $40,210 | $1,218 |
| Trulicity | 24 | $30,094 | $1,254 |
| Atrovent Hfa | 32 | $17,549 | $548 |
| Synjardy Xr | 16 | $15,685 | $980 |
See all 60 drugs
| Ozempic | 50 | $48,457 | $969 |
| Jardiance | 33 | $40,210 | $1,218 |
| Trulicity | 24 | $30,094 | $1,254 |
| Atrovent Hfa | 32 | $17,549 | $548 |
| Synjardy Xr | 16 | $15,685 | $980 |
| Belbuca | 11 | $7,767 | $706 |
| Xarelto | 11 | $7,475 | $680 |
| Basaglar Kwikpen U-100 | 21 | $6,868 | $327 |
| Budesonide-Formoterol | 14 | $2,853 | $204 |
| Gabapentin | 95 | $1,648 | $17 |
| Ultra-Fine Nano Pen Needle | 16 | $1,224 | $76 |
| Albuterol Sulfate Hfa | 35 | $1,222 | $35 |
| Atorvastatin | 211 | $1,164 | $6 |
| Levothyroxine | 92 | $1,006 | $11 |
| Insulin Aspart Prot Mix 70-30 | 12 | $901 | $75 |
| Famotidine | 53 | $833 | $16 |
| Metoprolol | 56 | $767 | $14 |
| Fluticasone Propionate | 77 | $713 | $9 |
| Chlorthalidone | 37 | $649 | $18 |
| Fosinopril | 42 | $602 | $14 |
| Loperamide | 14 | $583 | $42 |
| Losartan | 79 | $559 | $7 |
| Ezetimibe | 14 | $511 | $37 |
| Benazepril | 28 | $482 | $17 |
| Omeprazole | 63 | $481 | $8 |
| Metformin | 81 | $479 | $6 |
| Tamsulosin | 46 | $431 | $9 |
| Amlodipine Besylate | 125 | $424 | $3 |
| Diclofenac | 27 | $416 | $15 |
| Pantoprazole | 38 | $410 | $11 |
| Mirtazapine | 19 | $365 | $19 |
| Sertraline | 26 | $346 | $13 |
| Baclofen | 42 | $330 | $8 |
| Metoprolol | 51 | $306 | $6 |
| Ketoconazole | 20 | $277 | $14 |
| Hydrocodone-Acetaminophen | 28 | $264 | $9 |
| Hydralazine | 19 | $259 | $14 |
| Lisinopril | 49 | $255 | $5 |
| Duloxetine | 23 | $245 | $11 |
| Hydrocortisone | 16 | $240 | $15 |
| Pravastatin | 22 | $234 | $11 |
| Furosemide | 44 | $222 | $5 |
| Azelastine | 13 | $215 | $17 |
| Celecoxib | 13 | $166 | $13 |
| Metformin Hcl Er | 25 | $157 | $6 |
| Ibuprofen | 28 | $157 | $6 |
| Simvastatin | 30 | $155 | $5 |
| Alendronate | 20 | $148 | $7 |
| Nitrofurantoin Mono-Macro | 11 | $142 | $13 |
| Atenolol | 25 | $126 | $5 |
| Hydroxyzine | 15 | $118 | $8 |
| Triamcinolone Acetonide | 35 | $114 | $3 |
| Clopidogrel | 23 | $110 | $5 |
| Montelukast | 12 | $105 | $9 |
| Carvedilol | 13 | $96 | $7 |
| Glipizide | 16 | $86 | $5 |
| Trazodone | 19 | $70 | $4 |
| Hydrochlorothiazide | 29 | $62 | $2 |
| Tramadol | 14 | $45 | $3 |
| Cyclobenzaprine | 11 | $35 | $3 |
Year by year
| 2024 | 2,595 | 226 | 2% (56) | 15% | $287,136 |
| 2023 | 1,392 | 185 | 3% (37) | 13% | $149,015 |
| 2022 | 93 | 31 | None | None | $12,817 |
| 2016 | 72 | 45 | None | 15% | $2,665 |
| 2015 | 505 | 131 | None | 18% | $36,134 |
| 2014 | 2,604 | 179 | 5% (135) | 17% | $141,194 |
| 2013 | 2,660 | 165 | 5% (135) | 17% | $134,455 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 38 drugs
| Jardiance | 15 | $24,794 | $1,653 |
| Trulicity | 14 | $13,188 | $942 |
| Atrovent Hfa | 11 | $5,410 | $492 |
| Gabapentin | 69 | $2,586 | $37 |
| Atorvastatin | 106 | $2,366 | $22 |
| Tamsulosin | 34 | $2,130 | $63 |
| Losartan | 41 | $1,178 | $29 |
| Metformin | 35 | $1,060 | $30 |
| Chlorthalidone | 21 | $972 | $46 |
| Famotidine | 21 | $904 | $43 |
| Albuterol Sulfate Hfa | 22 | $830 | $38 |
| Lisinopril | 47 | $797 | $17 |
| Levothyroxine | 38 | $795 | $21 |
| Amlodipine Besylate | 60 | $738 | $12 |
| Fluocinonide | 11 | $733 | $67 |
| Fluticasone Propionate | 39 | $705 | $18 |
| Fosinopril | 25 | $664 | $27 |
| Omeprazole | 33 | $592 | $18 |
| Atenolol | 12 | $577 | $48 |
| Baclofen | 30 | $551 | $18 |
| Celecoxib | 16 | $532 | $33 |
| Metformin Hcl Er | 15 | $431 | $29 |
| Diclofenac | 17 | $418 | $25 |
| Pantoprazole | 19 | $416 | $22 |
| Buspirone | 14 | $388 | $28 |
| Benazepril | 15 | $351 | $23 |
| Hydrocortisone | 17 | $325 | $19 |
| Sertraline | 17 | $269 | $16 |
| Furosemide | 28 | $267 | $10 |
| Glipizide | 12 | $221 | $18 |
| Metoprolol | 14 | $174 | $12 |
| Simvastatin | 11 | $161 | $15 |
| Ibuprofen | 13 | $153 | $12 |
| Tramadol | 12 | $144 | $12 |
| Triamcinolone Acetonide | 23 | $142 | $6 |
| Metoprolol | 16 | $127 | $8 |
| Hydroxyzine | 15 | $90 | $6 |
| Cyclobenzaprine | 13 | $21 | $2 |
2015: 14 drugs
| Tamsulosin | 15 | $755 | $50 |
| Glipizide | 21 | $343 | $16 |
| Metoprolol | 18 | $296 | $16 |
| Insulin | 16 | $287 | $18 |
| Atorvastatin | 18 | $286 | $16 |
| Fosinopril | 13 | $274 | $21 |
| Amlodipine Besylate | 49 | $182 | $4 |
| Atenolol | 34 | $181 | $5 |
| Losartan | 17 | $132 | $8 |
| Metformin | 26 | $131 | $5 |
| Clopidogrel | 16 | $126 | $8 |
| Benazepril | 11 | $117 | $11 |
| Omeprazole | 14 | $99 | $7 |
| Hydrochlorothiazide | 12 | $54 | $4 |
2014: 54 drugs
| Nexium | 21 | $14,995 | $714 |
| Lantus | 37 | $13,928 | $376 |
| Crestor | 13 | $5,812 | $447 |
| Lantus Solostar | 11 | $5,776 | $525 |
| Advair Diskus | 13 | $5,186 | $399 |
| Avodart | 18 | $4,085 | $227 |
| Zetia | 15 | $2,887 | $192 |
| Fosinopril | 93 | $1,843 | $20 |
| Atorvastatin | 90 | $1,795 | $20 |
| Fenofibrate | 13 | $1,692 | $130 |
| Gabapentin | 64 | $1,484 | $23 |
| Omeprazole | 96 | $1,481 | $15 |
| Levothyroxine | 61 | $1,443 | $24 |
| Pravastatin | 45 | $1,393 | $31 |
| Metformin | 113 | $1,259 | $11 |
| Proair Hfa | 20 | $1,220 | $61 |
| Amlodipine Besylate | 210 | $1,205 | $6 |
| Hydrocodone-Acetaminophen | 85 | $1,192 | $14 |
| Doxazosin Mesylate | 21 | $1,155 | $55 |
| Tamsulosin | 32 | $1,127 | $35 |
| Clopidogrel | 43 | $1,019 | $24 |
| Baclofen | 51 | $1,003 | $20 |
| Glipizide | 72 | $982 | $14 |
| Fluticasone Propionate | 48 | $852 | $18 |
| Bd Ultra-Fine Pen Needle | 19 | $773 | $41 |
| Atenolol | 132 | $760 | $6 |
| Hydralazine | 27 | $722 | $27 |
| Glyburide | 14 | $717 | $51 |
| Metoprolol | 86 | $693 | $8 |
| Simvastatin | 70 | $615 | $9 |
| Triamcinolone Acetonide | 25 | $610 | $24 |
| Losartan | 39 | $602 | $15 |
| Insulin | 25 | $453 | $18 |
| Carvedilol | 21 | $371 | $18 |
| Alendronate | 30 | $363 | $12 |
| Benazepril | 33 | $361 | $11 |
| Lactulose | 11 | $336 | $31 |
| Hydrochlorothiazide | 66 | $268 | $4 |
| Acetaminophen-Codeine | 34 | $251 | $7 |
| Sertraline | 20 | $250 | $12 |
| Nitrostat | 15 | $246 | $16 |
| Econazole Nitrate | 11 | $192 | $17 |
| Meclizine | 12 | $191 | $16 |
| Trazodone | 32 | $185 | $6 |
| Furosemide | 33 | $165 | $5 |
| Allopurinol | 16 | $135 | $8 |
| Lisinopril | 26 | $112 | $4 |
| Ranitidine | 14 | $105 | $8 |
| Hydroxyzine | 11 | $104 | $9 |
| Clonidine | 13 | $87 | $7 |
| Meloxicam | 15 | $65 | $4 |
| Ibuprofen | 13 | $62 | $5 |
| Famotidine | 11 | $62 | $6 |
| Lorazepam | 15 | $58 | $4 |
2013: 58 drugs
| Lantus | 41 | $11,745 | $286 |
| Nexium | 15 | $8,894 | $593 |
| Aggrenox | 17 | $7,649 | $450 |
| Qvar | 24 | $6,157 | $257 |
| Novolog Mix 70-30 | 11 | $4,841 | $440 |
| Crestor | 11 | $4,833 | $439 |
| Avodart | 15 | $3,923 | $262 |
| Atorvastatin | 74 | $2,563 | $35 |
| Amlodipine Besylate | 224 | $2,384 | $11 |
| Flovent Hfa | 12 | $2,362 | $197 |
| Fosinopril | 103 | $2,205 | $21 |
| Clopidogrel | 22 | $2,156 | $98 |
| Omeprazole | 114 | $2,052 | $18 |
| Metformin | 134 | $1,982 | $15 |
| Losartan | 45 | $1,461 | $32 |
| Glipizide | 93 | $1,395 | $15 |
| Tamsulosin | 30 | $1,375 | $46 |
| Pravastatin | 50 | $1,292 | $26 |
| Fluticasone Propionate | 51 | $1,237 | $24 |
| Proair Hfa | 25 | $1,231 | $49 |
| Gabapentin | 30 | $1,111 | $37 |
| Simvastatin | 97 | $1,098 | $11 |
| Levothyroxine | 64 | $975 | $15 |
| Isosorbide Dinitrate | 13 | $973 | $75 |
| Atenolol | 132 | $925 | $7 |
| Doxazosin Mesylate | 26 | $917 | $35 |
| Alendronate | 51 | $793 | $16 |
| Montelukast | 12 | $685 | $57 |
| Hydrocodone-Acetaminophen | 72 | $673 | $9 |
| Metoprolol | 67 | $666 | $10 |
| Bd Ultra-Fine Pen Needle | 17 | $602 | $35 |
| Hydralazine | 24 | $566 | $24 |
| Baclofen | 51 | $527 | $10 |
| Benazepril | 45 | $501 | $11 |
| Triamcinolone Acetonide | 13 | $349 | $27 |
| Acetaminophen-Codeine | 43 | $338 | $8 |
| Econazole Nitrate | 19 | $321 | $17 |
| Nabumetone | 11 | $308 | $28 |
| Oxycodone-Acetaminophen | 18 | $308 | $17 |
| Furosemide | 44 | $303 | $7 |
| Carvedilol | 20 | $301 | $15 |
| Hydrochlorothiazide | 68 | $284 | $4 |
| Insulin | 16 | $274 | $17 |
| Sertraline | 18 | $261 | $15 |
| Clonidine | 15 | $240 | $16 |
| Pantoprazole | 16 | $204 | $13 |
| Triamterene-Hctz | 12 | $195 | $16 |
| Insulin | 11 | $187 | $17 |
| Trazodone | 19 | $135 | $7 |
| Cyclobenzaprine | 16 | $109 | $7 |
| Meloxicam | 13 | $104 | $8 |
| Famotidine | 16 | $101 | $6 |
| Lisinopril | 14 | $85 | $6 |
| Allopurinol | 13 | $80 | $6 |
| Metoclopramide | 11 | $77 | $7 |
| Propranolol | 11 | $56 | $5 |
| Ibuprofen | 12 | $56 | $5 |
| Amitriptyline | 11 | $36 | $3 |
Professional record
- NPI
- 1780640524
- Licence
- CA A68064California A68064: Current · expires 2028-08-31
- Trained
- Oakland College of Medicine and Surgery, 1997 · 29 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A680640
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 751 S Bascom Ave, San Jose, CA, 95128
- NPI first listed
- 2006-04-21
- NPI last updated
- 2007-09-12
This is when the NPI record was last certified, not a medical board exam.